The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model
Open accessAbstract
Abstract Zika virus (ZIKV) is an emerging flavivirus typically causing a dengue-like febrile illness, but neurological complications, such as microcephaly in newborns, have potentially been linked to this viral infection. We established a panel of in vitro assays to allow the identification of ZIKV inhibitors and demonstrate that the viral polymerase inhibitor 7-deaza-2’- C -methyladenosine (7DMA) efficiently inhibits replication. Infection of AG129 (IFN-α/β and IFN-γ receptor knockout) mice with ZIKV resulted in acute neutrophilic encephalitis with viral antigens accumulating in neurons of the brain and spinal cord. Additionally, high levels of viral RNA were detected in the spleen, liver and kidney, and levels of IFN-γ and IL-18 were systematically increased in serum of ZIKV-infected mice. Interestingly, the virus was also detected in testicles of infected mice. In line with its in vitro anti-ZIKV activity, 7DMA reduced viremia and delayed virus-induced morbidity and mortality in infected mice, which also validates this small animal model to assess the in vivo efficacy of novel ZIKV inhibitors. Since AG129 mice can generate an antibody response, and have been used in dengue vaccine studies, the model can also be used to assess the efficacy of ZIKV vaccines. Article Summary Line: A robust cell-based antiviral assay was developed that allows to screen for and validate novel inhibitors of Zika virus (ZIKV) replication. The viral polymerase inhibitor 7-deaza-2’- C -methyladenosine (7DMA) was identified as a potent ZIKV inhibitor. A mouse model for ZIKV infections, which was validated for antiviral studies, demonstrated that 7DMA markedly delays virus-induced disease in this model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zika Virus (I). Isolations and serological specificity
Dick, G. W. A., Kitchen, S. F., & Haddow, A. J. (1952) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(52)90042-4 · Cited by 2,692
Biology of Zika Virus Infection in Human Skin Cells
Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., Perera-Lecoin, M., Surasombatpattana, P., Talignani, L., Thomas, F., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00354-15 · Cited by 1,207
Potential Sexual Transmission of Zika Virus
Musso, D., Roche, C., Robin, E., Nhan, T., Teissier, A., & Cao-Lormeau, V.-M. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2102.141363 · Cited by 1,176
Probable Non–Vector-borne Transmission of Zika Virus, Colorado, USA
Foy, B. D., Kobylinski, K. C., Foy, J. L. C., Blitvich, B. J., Travassos da Rosa, A., Haddow, A. D., Lanciotti, R. S., & Tesh, R. B. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1705.101939 · Cited by 1,156
Zika Virus Outbreak, Bahia, Brazil
Campos, G. S., Bandeira, A. C., & Sardi, S. I. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2110.150847 · Cited by 1,146
Zika Virus in the Americas — Yet Another Arbovirus Threat
Fauci, A. S., & Morens, D. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1600297 · Cited by 1,069
Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastère, S., Valour, F., Baudouin, L., Mallet, H. P., Musso, D., & Ghawche, F. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.9.20720 · Cited by 1,016
Zika Virus, French Polynesia, South Pacific, 2013
Cao-Lormeau, V.-M., Roche, C., Teissier, A., Robin, E., Berry, A.-L., Mallet, H.-P., Sall, A. A., & Musso, D. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2006.140138 · Cited by 874
Genetic Characterization of Zika Virus Strains: Geographic Expansion of the Asian Lineage
Haddow, A. D., Schuh, A. J., Yasuda, C. Y., Kasper, M. R., Heang, V., Huy, R., Guzman, H., Tesh, R. B., & Weaver, S. C. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001477 · Cited by 773
Zika Virus in Gabon (Central Africa) – 2007: A New Threat from Aedes albopictus?
Grard, G., Caron, M., Mombo, I. M., Nkoghe, D., Mboui Ondo, S., Jiolle, D., Fontenille, D., Paupy, C., & Leroy, E. M. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002681 · Cited by 704
Rapid spread of emerging Zika virus in the Pacific area
Musso, D., Nilles, E. J., & Cao-Lormeau, V.-M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12707 · Cited by 686
Veterinary toxicology: basic and clinical principles.
Gupta, R. C. (2007) · Cited by 675
Current Zika virus epidemiology and recent epidemics
Ioos, S., Mallet, H.-P., Leparc Goffart, I., Gauthier, V., Cardoso, T., & Herida, M. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.04.008 · Cited by 590
Zika Virus, French Polynesia, South Pacific, 2013
Cao-Lormeau, V.-M. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.141380 · Cited by 442
Zika Virus Emergence in Mosquitoes in Southeastern Senegal, 2011
Diallo, D., Sall, A. A., Diagne, C. T., Faye, O., Faye, O., Ba, Y., Hanley, K. A., Buenemann, M., Weaver, S. C., & Diallo, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109442 · Cited by 373
Zika Virus Transmission from French Polynesia to Brazil
Musso, D. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2010.151125 · Cited by 356
Schul, W., Liu, W., Xu, H., Flamand, M., & Vasudevan, S. G. (2007) · The Journal of Infectious Diseases · doi:10.1086/511310 · Cited by 246
Iversen, P. W., Eastwood, B. J., Sittampalam, G. S., & Cox, K. L. (2006) · SLAS Discovery · doi:10.1177/1087057105285610 · Cited by 237
Zammarchi, L., Stella, G., Mantella, A., Bartolozzi, D., Tappe, D., Günther, S., Oestereich, L., Cadar, D., Muñoz-Fontela, C., Bartoloni, A., et al. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.12.005 · Cited by 181
Rathore, A. P. S., Paradkar, P. N., Watanabe, S., Tan, K. H., Sung, C., Connolly, J. E., Low, J., Ooi, E. E., & Vasudevan, S. G. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.10.002 · Cited by 165
Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase
Tappe, D., Pérez-Girón, J. V., Zammarchi, L., Rissland, J., Ferreira, D. F., Jaenisch, T., Gómez-Medina, S., Günther, S., Bartoloni, A., Muñoz-Fontela, C., et al. (2016) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0445-7 · Cited by 161
Pétrilli, V., Papin, S., & Tschopp, J. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.049 · Cited by 160
Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014
Kutsuna, S., Kato, Y., Takasaki, T., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.4.20683 · Cited by 150
Zika: the new arbovirus threat for Latin America
Rodriguez-Morales, A. J. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7230 · Cited by 138
Zika virus infection in a traveller returning to Europe from Brazil, March 2015
Zammarchi, L., Tappe, D., Fortuna, C., et al. (2015) · Eurosurveillance · doi:10.2807/1560-7917.es2015.20.23.21153 · Cited by 134
Paeshuyse, J., Dallmeier, K., & Neyts, J. H. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.030 · Cited by 116
Self-citationZika virus spreads across Americas as concerns mount over birth defects
Dyer, O. (2015) · BMJ · doi:10.1136/bmj.h6983 · Cited by 103
Zika Virus Infection after Travel to Tahiti, December 2013
Wæhre, T., Maagard, A., Tappe, D., et al. (2014) · Emerging infectious diseases · doi:10.3201/eid2008.140302 · Cited by 93
Sarathy, V. V., White, M. M., Li, L., Gorder, S. R., Pyles, R. B., Campbell, G. A., Milligan, G. N., Bourne, N., & Barrett, A. D. T. (2014) · Journal of Virology · doi:10.1128/jvi.01320-14 · Cited by 87
Mouse models of dengue virus infection for vaccine testing
Sarathy, V. V., Milligan, G. N., Bourne, N., & Barrett, A. D. T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.112 · Cited by 66
First US case of Zika virus infection is identified in Texas
McCarthy, M. C. (2016) · BMJ · doi:10.1136/bmj.i212 · Cited by 48
Toxicity of over-the-counter drugs
Bischoff, K. L., & Mukai, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385926-6.00028-4 · Cited by 5
Cited by
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
FURUTA, Y., KOMENO, T., & NAKAMURA, T. (2017) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.93.027 · Cited by 1,070
Krauer, F., Riesen, M., Reveiz, L., Oladapo, O. T., Martínez-Vega, R., Porgo, T. V., Haefliger, A., Broutet, N. J., Low, N., & WHO Zika Causality Working Group (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002203 · Cited by 492
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
Delang, L., Abdelnabi, R., & Neyts, J. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.03.003 · Cited by 388
Self-citationLi, C., Deng, Y.-Q., Wang, S., Ma, F., Aliyari, R., Huang, X.-Y., Zhang, N.-N., Watanabe, M., Dong, H.-L., Liu, P., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.012 · Cited by 344
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
Boldescu, V., Behnam, M. A. M., Vasilakis, N., & Klein, C. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.33 · Cited by 305
Metadata
- Authors
- Zmurko, J., Marques, R. E., Schols, D., Verbeken, E., Kaptein, S. J. F., & Neyts, J.
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-05-10
- Volume
- 10
- Issue
- 5
- Pages
- e0004695
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- OpenAlex
- W2392178457
- Cited by
- 292
- References
- 32
- FWCI
- 52.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.